EcoDrugPlus

Purinergic Receptor P2x 3

Ensembl ID : ENSPCTG00005012658
Gene Symbol: P2RX3
3 Cross references
270 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSPCTG00005000065
Gene Symbol: P2RY12
1 Cross references
180 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSPCTG00005020948
Gene Symbol: RPTOR
3 Cross references
209 Possible Orthologues:

Renin

Ensembl ID : ENSPCTG00005016497
Gene Symbol: REN
1 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPCTG00005018973
Gene Symbol: RET
1 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPCTG00005010616
Gene Symbol: RARG
3 Cross references
446 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPCTG00005004526
Gene Symbol: RXRA
1 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSPCTG00005011572
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSPCTG00005020944
Gene Symbol: RPL28
1 Cross references
206 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSPCTG00005012598
Gene Symbol: RPL3
3 Cross references
274 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSPCTG00005021386
Gene Symbol: RPL39
2 Cross references
18 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSPCTG00005010646
Gene Symbol: RPL8
1 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).